Group 1 - The company, 精锋医疗-B (02675), announced that the overall coordinator has fully exercised the over-allotment option, involving a total of 4.1583 million H shares, which accounts for approximately 15% of the total shares available for subscription under the global offering before any over-allotment options are exercised [1] - The over-allotment shares will be issued at a price of HKD 43.24 per H share, aimed at expediting the delivery of H shares to relevant subscribers who agreed to subscribe under the global offering [1] - The stabilization period for the global offering ended on February 4, 2026, which is the 30th day after the deadline for submitting applications for the Hong Kong public offering [1] Group 2 - During the stabilization period, the stabilization agent did not buy or sell any H shares in the market to stabilize the price [2]
精锋医疗-B超额配股权获悉数行使 稳定价格期间结束